False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Immunoassays are routinely used to provide rapid urine drug screening results in the clinical setting. These screening tests are prone to false-positive results and ideally require confirmation by mass spectrometry. In this study, we have examined a large number of urine specimens where drugs other than amphetamines may have caused a false-positive amphetamine immunoassay screening result. Urine drug screens (12,250) in a clinical laboratory that used the CEDIA amphetamine/ecstasy method were reviewed for false-positive results over a 6-year period (2015–2020). An additional 3,486 referred samples, for which confirmatory--mass spectrometry was requested, were also reviewed. About 86 in-house samples and 175 referral samples that were CEDIA false-positive screens were further analyzed by an LC–QTOF general unknown screen. Potential cross-reacting drugs were identified, and their molecular similarities to the CEDIA targets were determined. Commercial standards were also analyzed for cross-reactivity in the amphetamine/ecstasy CEDIA screen. Positive amphetamine results in 3.9% of in-house samples and 9.9% of referred tests for confirmatory analysis were false positive for amphetamines. Of these false-positive specimens, on average, 6.8 drugs were detected by the LC–QTOF screen. Several drugs were identified as possible cross-reacting drugs to the CEDIA amphetamine/ecstasy assay. Maximum common substructure scores for 70 potential cross-reacting compounds were calculated. This was not helpful in identifying cross-reacting drugs. False-positive amphetamine screens make up to 3.9–9.9% of positive amphetamine screens in the clinical laboratory. Knowledge of cross-reacting drugs may be helpful when mass spectrometry testing is unavailable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
False-Positive Interferences of Common Urine Drug Screen Immunoassays: A Review
Saitman, A., Park, H.-D., & Fitzgerald, R. L. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku075 · Cited by 334
A maximum common substructure-based algorithm for searching and predicting drug-like compounds
Cao, Y., Jiang, T., & Girke, T. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn186 · Cited by 210
Vazzana, M., Andreani, T., Fangueiro, J., Faggio, C., Silva, C., Santini, A., Garcia, M. L., Silva, A. M., & Souto, E. B. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.022 · Cited by 188
Database fingerprint (DFP): an approach to represent molecular databases
Gortari, E. F., García‐Jacas, C. R., Martínez‐Mayorga, K., & Medina‐Franco, J. L. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0195-1 · Cited by 108
Petrie, M. S., Lynch, K. L., Ekins, S., Chang, J. S., Goetz, R., Wu, A. H. B., & Krasowski, M. D. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.768344 · Cited by 62
Beck, O., Rausberg, L., Al‐Saffar, Y., Villén, T., Karlsson, L., Hansson, T., & Helander, A. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1641 · Cited by 60
Determination of Designer Drug Cross-Reactivity on Five Commercial Immunoassay Screening Kits
Regester, L. E., Chmiel, J. D., Holler, J. M., Vorce, S. P., LEVINE, B. S., & Bosy, T. Z. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku133 · Cited by 60
Frequency of False Positive Amphetamine Screens due to Bupropion Using the Syva Emit II Immunoassay
Casey, E. R., Scott, M. G., Tang, S., & Mullins, M. E. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0131-5 · Cited by 59
Dimethylamylamine: A Drug Causing Positive Immunoassay Results for Amphetamines
Vorce, S. P., Holler, J. M., Cawrse, B. M., & Magluilo, J. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.3.183 · Cited by 57
False-Positive Amphetamine Toxicology Screen Results in Three Pregnant Women Using Labetalol
Yee, L. M., & Wu, D. W. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318206c07c · Cited by 53
Research works printed but not linked: 1
- Varon, 2015, Determination of verapamil through LC-ESI-MS-MS in a case of fatal intoxication, Rev Case Reports, 1, 23
Cited by
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
(2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001299 · Cited by 78
Lu, R., Jiang, Y., Du, Z., Zhou, Q., Shen, Y., & Zhu, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.085 · Cited by 22
McMillin, G. A., Morad, A., Boyd, J. M., Johnson‐Davis, K. L., Metz, T. D., Smid, M. C., & Krasowski, M. D. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae018 · Cited by 13
Możdżeń, K., Kaleta, K., Murawska, A., Pośpiech, J., Panek, P., Lorkowska-Zawicka, B., & Bujak-Giżycka, B. (2023) · Folia Medica Cracoviensia · doi:10.24425/fmc.2023.145917 · Cited by 10
Battini, V., Cirnigliaro, G., Giacovelli, L., Boscacci, M., Manzo, S. M., Mosini, G., Guarnieri, G., Gringeri, M., Benatti, B., Clementi, E., et al. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2211261 · Cited by 10
Cost-Effective Drug Testing: Analytical Methodology, Best Practices, and Clinical Utility
Chenoweth, J., LaValley, C., Eberhardt, C. S., Colby, D. K., Albertson, T. E., & Tran, N. K. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae118 · Cited by 8
Definitive urine drug testing in emergency medicine: Recreational and psychiatric drug findings
ROSANO, T. G., Islam, S., Rumberger, J. M., Konetchy, R. M., Wood, M., Sorce, J. A., Robstad, K., & Long, H. (2025) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2025.04.008 · Cited by 6
Kang, B., Shin, S., Kim, J., Kang, M., Lee, D.-H., Jeon, S., & Bang, M. (2024) · Journal of Korean Medicine for Obesity Research · doi:10.15429/jkomor.2024.24.1.94 · Cited by 6
Advances, Nuances, and Future Directions in Neonatal Toxicology Testing
Gold, C., Bourque, S. L., Wagner, K., Wymore, E. M., & Halmo, L. S. (2025) · NeoReviews · doi:10.1542/neo.26-4-007 · Cited by 4
Clinical Drug Testing Supporting Patients with Substance Use Disorder: A Review
Saitman, A. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf069 · Cited by 3
False positive urine drug screens
Saitman, A., Fitzgerald, R. L., Lund, K., Suhandynata, R. T., & Menlyadiev, M. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag007 · Cited by 3
Interpol review of forensic toxicology, 2023–2025
Ip, S. C.-Y., Chan, C.-W., Chan, C.-W., Chu, A., Chung, W.-W., Hui, J. W.-S., Ku, K.-W., Lee, W., Lo, K.-M., Poon, K.-C., et al. (2026) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2026.100694 · Cited by 3
Willeman, T., Laudet, M., Revol, B., Boudin, C., Eysseric, H., Scolan, V., & Stanke‐Labesque, F. (2025) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632251331404 · Cited by 2
Ischemic Evaluation in New‐Onset Methamphetamine‐Associated Heart Failure
Kersey, C. B., Hidano, D., Chiang, J. C., Doshi, S., & Longenecker, C. T. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037339 · Cited by 1
Carpentier, E. C. L., Helesbeux, M., Biering, V., Aquizerate, A., Rousselet, M., Barrangou-Poueys-Darlas, M., Verholleman, A., Dailly, É., Grégoire, M., Victorri‐Vigneau, C., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111465 · Cited by 1
Laboratory testing in the poisoned patient
Hoffman, R. J., Aloumi, A., & Cao, D. (2026) · Archives of Disease in Childhood · doi:10.1136/archdischild-2025-329429 · Cited by 1
dos Santos, B. P., Pôrto, V. C., Birk, L., Nascimento, S., Sebben, V. C., Eller, S. C. W. D. S., & de Oliveira, T. F. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2686365 · Cited by 1
Sainz-Pastor, N., Martín, E. C. S., Julià, E., Sabau, L. C., Navas, E., Alcaraz‐Quiles, J., de la Presa, B. G., & Parra‐Robert, M. (2026) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2026.2694040 · Cited by 1
Residents’ Knowledge regarding Recreational Drug Screening Immunoassays at a Swiss Hospital Group
Bekka, E., Christen, S. E., Hermann, L. L., Exadaktylos, A. K., Haschke, M., & Liakoni, E. (2024) · International Journal of Analytical Chemistry · doi:10.1155/2024/4400606
Cardiac Medications Causing False-Positive Illicit Drug Results: A Case Report.Preprint
Somma, V., Ellims, A., Voskoboinik, A., Gutman, S., & Paratz, E. D. (2025) · doi:10.22541/au.173977580.03414816/v1
Management of Drug Overdose and Intoxications in the ICU
Calnan, L. R., & Gass, J. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_37
Silverman, M., Thandrasisla, P., Lam, M., Forchuk, C., Rudnick, A., Lee, K., Koivu, S. L., Lodhi, R. J., Guarasci, E., Serrato, J., et al. (2025) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000258
Defending Positive Amphetamine Results
Choucair, I. (2026) · Springer eBooks · doi:10.1007/978-3-032-15015-8_12
Nicardipine-induced false positive for amphetamines in a post-mortem immunoassay: A case report
Zergui, A., & Chefirat, B. (2026) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2026.05.001
Whole-Process Analysis: A Spatiotemporal AI Paradigm for High-Precision Point of Care TestPreprint
Liu, M., Sun, P., Ovi, N. H., Peng, Z., Liu, Z., Wasim, M., Yuan, Q., Kuruva, P., de Araujo, I. B., Ma, Y., et al. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15007405/v1
Moncef, B., Tassadit, M. R., Cheima, B., Salima, E. E., & Kaddour, S. (2026) · Acta Clinica Belgica · doi:10.1080/17843286.2026.2724290
Roberts, D. M., Ionmhain, Ú. N., Trakulsrichai, S., Peter, J. V., Hassanian‐Moghaddam, H., & Wood, D. M. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00736-4
Active Noise Cancelling in Point-of-Care TestingPreprint
Liu, M., Sun, P., Ovi, N. H., Peng, Z., Liu, Z., Wasim, M., Yuan, Q., Kuruva, P., de Araujo, I. B., Ma, Y., et al. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15007405/v2
Rasool, F. A., Sabah, R., & Muklive, A. J. (2026) · Research Square · doi:10.21203/rs.3.rs-11253842/v1
Karnani, S., Pico-Picos, M. Á., Villacampa-Jiménez, J. J., Laburu-Dañobeitia, E., Cabana-Ramos, D., Matey, J. M., & Menéndez-Quintanal, L. M. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-1205
Metadata
- Authors
- Pope, J. D., Drummer, O. H., & Schneider, H. G.
- Affiliations
- The Alfred Hospital (AU)
- Victorian Institute of Forensic Medicine (AU)
- Corresponding author
- Pope, Jeffrey D
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-11-11
- Volume
- 47
- Issue
- 3
- Pages
- 263-270
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W4308771126
- Cited by
- 25
- References
- 38
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 6 · 2023: 2
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- false positives, urine drug testing, cross-reactivity, immunoassay interference, confirmatory testing, maximum common substructure, drug screening
- MeSH terms
- Amphetamine, Amphetamines, Immunoassay, Mass Spectrometry, Substance Abuse Detection, N-Methyl-3,4-methylenedioxyamphetamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.